Salkeld Alison L, Unicomb Kylie, Hayden Amy J, Van Tilburg Kevin, Yau Shan, Tiver Kenneth
Nepean Cancer Care Centre, Nepean Hospital, Sydney, New South Wales, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia.
J Med Imaging Radiat Oncol. 2014 Dec;58(6):722-8. doi: 10.1111/1754-9485.12188. Epub 2014 Jun 10.
The purpose of this study is to compare and evaluate volumetric modulated arc therapy (VMAT) and linear accelerator-based radiosurgery (Linac RS) for the treatment of one to four brain metastases.
Radiotherapy plans for 10 patients with 1 to 4 brain metastases that were planned and treated using conventional Linac RS were replanned using a mono-isocentric VMAT technique using two to four arcs. The same doses, target volumes and organs at risk (OAR) were used in both plans. The plans were evaluated for target volume coverage, dose conformity, homogeneity and dose to OAR.
For VMAT plans, 18/19 brain metastases met acceptable Radiation Therapy Oncology Group (RTOG) radiosurgery dose coverage, homogeneity and conformity criteria. There was no observed difference between the mean homogeneity indices for VMAT and Linac RS plans. VMAT plans had a lower mean RTOG conformity index compared with the Linac RS plans (1.10 ± 0.06 versus 2.06 ± 1.02). For the OAR, there was no difference in maximal doses to the brain stem, optic chiasm or optic nerves. The volume of normal brain receiving 12 Gy was lower in the VMAT plans (13.3 cm(3) versus 23.1 cm(3) ) compared with the Linac RS plans. The mean total number of monitor units (MUs) was 31.3% less in the VMAT plans (5231.2 MU versus 3593.5 MU).
Mono-isocentric VMAT plans using two to four arcs meet RTOG radiosurgery quality criteria in patients with one to four brain metastases, with an improvement in conformity and 12-Gy normal brain volume when compared with patients treated with Linac RS at our institution.
本研究的目的是比较和评估容积调强弧形放疗(VMAT)和基于直线加速器的放射外科治疗(直线加速器放射外科,Linac RS)用于治疗1至4个脑转移瘤的效果。
对10例有1至4个脑转移瘤且采用传统直线加速器放射外科进行计划和治疗的患者放疗计划,使用单等中心VMAT技术、两至四个弧进行重新计划。两个计划均采用相同的剂量、靶区体积和危及器官(OAR)。对计划的靶区体积覆盖、剂量适形度、均匀性和OAR剂量进行评估。
对于VMAT计划,19个脑转移瘤中有18个符合可接受的放射治疗肿瘤学组(RTOG)放射外科剂量覆盖、均匀性和适形度标准。VMAT和直线加速器放射外科计划的平均均匀性指数之间未观察到差异。与直线加速器放射外科计划相比,VMAT计划的平均RTOG适形指数更低(1.10±0.06对2.06±1.02)。对于OAR,脑干、视交叉或视神经的最大剂量没有差异。与直线加速器放射外科计划相比,VMAT计划中接受12 Gy照射的正常脑体积更低(13.3 cm³对23.1 cm³)。VMAT计划的平均总监测单位(MU)数减少了31.3%(5231.2 MU对3593.5 MU)。
使用两至四个弧的单等中心VMAT计划符合1至4个脑转移瘤患者的RTOG放射外科质量标准,与我院接受直线加速器放射外科治疗的患者相比,适形度和12 Gy正常脑体积有所改善。